Our partnership with the uMed research platform

The Abingdon Surgery is currently working with a research technology partner known as uMed. Their accredited platform enables us to provide you with research opportunities that are highly relevant to your health circumstances.

Without the use of uMed’s technology we may not have the time to find and engage patients that meet the requirements of the studies. This would therefore mean many patients would miss out on their chance to participate in ground-breaking research.

For further information on uMed please visit their website at www.umed.io or email [email protected]

Practice Privacy Notice Statement

Supporting Research Activity

The Abingdon Surgery uses Umedeor Ltd (uMed) as a data processor to support research and care support activity. This includes accessing and secure hosting of health record data for the purpose of identifying patients that are eligible for specific research or care support projects. uMed also contacts those patients on behalf of the practice via SMS, letter, email or telephone to provide more information about the study, and to collect additional information to assess your eligibility for a certain study.

Your consent will be required before any practice data is shared externally with researchers. uMed applies the national opt-out to practice data it receives so if you wish your data is not processed for research you can do so by visiting https://www.nhs.uk/your-nhs-data-matters/

For further information on uMed please visit their website at www.umed.io or email [email protected]

ACCESS Registries

The Abingdon Surgery is taking part in several studies known as ACCESS Registries, run by our research technology partner uMed. These registry studies follow participants over time and collect information provided by you, on your own terms, from the comfort of your own home. This provides researchers with invaluable data about different diseases and conditions. The data collection can be in the form of questionnaires, medical device data and DNA testing.

These ACCESS Registries are currently enrolling patients who have been diagnosed with the following conditions:

  • Parkinson’s Disease (AccessPD registry)
  • Interstitial Lung Disease (AccessILD registry)
  • Cardiometabolic Disease (AccessCMD registry)

If you’d like to find out more about these studies and what would be involved if you decided to participate please contact uMed’s nurse support team at [email protected]